Fenretinide derivatives act as disrupters of interactions of serum retinol binding protein (sRBP) with transthyretin and the sRBP receptor - Campos-Sandoval, J A; Redondo, C; Kinsella, G K; Pal, A; Jones, G; Hirst, S C; Findlay, J B (J Med Chem, 2011)